Latest Breaking News On - Green room communications - Page 3 : comparemela.com

EyePoint Pharmaceuticals Announces Two Presentations of Topline Data with Additional Subgroup Analyses from the Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Treatment of Wet Age-Related Macular Degeneration

Subgroup analyses underscore favorable clinical profile and durability of EYP-1901Presentations highlight previously reported positive Phase 2 DAVIO 2 topline results showing all primary and secondary.

United statesMacau generalHong kongCarl regilloJay dukerChristina tartagliaCharlesc wykoffAmy phillipsGlobenewswire incEyepoint pharmaceuticals nasdaqThomas jefferson universityEyepoint pharmaceuticals incExchange commissionEquinox sciencesEyepoint pharmaceuticalsGreen room communications

EyePoint Pharmaceuticals Announces Two Presentations of Topline Data with Additional Subgroup Analyses from the Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Treatment of Wet Age-Related Macular Degeneration

EyePoint Pharmaceuticals Announces Two Presentations of Topline Data with Additional Subgroup Analyses from the Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Treatment of Wet Age-Related Macular Degeneration
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongMacau generalCarl regilloJay dukerCharlesc wykoffChristina tartagliaAmy phillipsGreen room communicationsExchange commissionEyepoint pharmaceuticalsThomas jefferson universityDrug administrationEquinox sciencesEyepoint pharmaceuticals nasdaqEyepoint pharmaceuticals inc

Mallinckrodt Presents New Data on TERLIVAZ® (terlipressin) for Injection at the Society of Critical Care Medicine (SCCM) 2024 Critical Care Congress

Mallinckrodt Presents New Data on TERLIVAZ® (terlipressin) for Injection at the Society of Critical Care Medicine (SCCM) 2024 Critical Care Congress
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomPrnewswire mallinckrodtDerek belzJodyc olsonPeter richardsonDanielj specialeSociety of critical care medicineNational organization for rare disordersDepartment of internal medicineMallinckrodt hospital products incGreen room communicationsMallinckrodt pharmaceuticalsCritical care congressPresents new dataCritical care medicine

EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 2 VERONA Clinical Trial of EYP-1901 for the Treatment of Diabetic Macular Edema

EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 2 VERONA Clinical Trial of EYP-1901 for the Treatment of Diabetic Macular Edema
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMacau generalHong kongChristina tartagliaAmy phillipsJay dukerGreen room communicationsEyepoint pharmaceuticals nasdaqExchange commissionEyepoint pharmaceuticalsEquinox sciencesEyepoint pharmaceuticals incDrug administrationDiabetic macularPoint pharmaceuticalsChief executive officer

Mallinckrodt Announces Journal Publication of Economic Evidence for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS)

Mallinckrodt Announces Journal Publication of Economic Evidence for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPrnewswire mallinckrodtDanielj specialeDerek belzMallinckrodt hospital products incEvidence generation data sciencesGreen room communicationsMallinckrodt pharmaceuticalsNational organization for rare disordersImportant safety informationBoxed warningRelated cost analysisHepatorenal syndromeRapid reductionKidney functionVice president